Clincosm LogoSign in Get a demo

Alzheimer Disease

Showing NaN - NaN of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
Has Results
  • Alzheimer Disease
  • Birmingham, Alabama
  • +286 more
May 3, 2016

Alzheimer Trial in United States (ACC-001+ QS21 (3mcg), ACC-001 (10 mcg) + QS-21, ACC-001+QS-21 (30mcg))

Terminated
Has Results
  • Alzheimer Disease
  • ACC-001+ QS21 (3mcg)
  • +2 more
  • Phoenix, Arizona
  • +27 more
Mar 2, 2016

Alzheimer Trial in United States ([18F]NAV4694)

Unknown status
  • Alzheimer Disease
  • New Haven, Connecticut
  • +6 more
Mar 29, 2016

Alzheimer Trial in Worldwide (bapineuzumab, )

Terminated
Has Results
  • Alzheimer Disease
  • Birmingham, Alabama
  • +347 more
Dec 4, 2015

Alzheimer Trial in United States (ACC-001 + QS-21, QS-21, Diluent: Phosphate Buffered Saline)

Completed
Has Results
  • Alzheimer Disease
  • ACC-001 + QS-21
  • +3 more
  • Phoenix, Arizona
  • +26 more
Nov 30, 2015

Alzheimer Trial in United States (Valproate, Placebo)

Completed
Has Results
  • Alzheimer Disease
  • Sun City, Arizona
  • +45 more
Sep 15, 2014

Alzheimer, Amyloid Beta-Protein Trial in Worldwide (Florbetaben (BAY94-9172))

Completed
Has Results
  • Alzheimer Disease
  • Amyloid Beta-Protein
  • Florbetaben (BAY94-9172)
  • Sun City, Arizona
  • +22 more
Jul 15, 2014

Parkinson Disease, Alzheimer Trial in New Haven ([18F] CFPyPB)

Completed
  • Parkinson Disease
  • Alzheimer Disease
  • [18F] CFPyPB
  • New Haven, Connecticut
    Institute_Neurodegenerative_Disorders
Jun 2, 2014

Alzheimer, Parkinson Disease Trial in New Haven ([123I]-IBVM)

Completed
  • Alzheimer Disease
  • Parkinson Disease
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 16, 2014

Alzheimer Trial in New Haven ([123I] IMPY & SPECT Imaging)

Completed
  • Alzheimer Disease
  • [123I] IMPY & SPECT Imaging
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Mar 6, 2014

Alzheimer Trial in New Haven ([18F]-FMH3)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Nov 8, 2013

Alzheimer Trial in New Haven ([18F] PBR111)

Completed
  • Alzheimer Disease
  • [18F] PBR111
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Nov 8, 2013

Alzheimer Trial in Worldwide (Dimebon 20 mg po TID, Placebo po TID)

Terminated
Has Results
  • Alzheimer Disease
  • Dimebon 20 mg po TID
  • Placebo po TID
  • Phoenix, Arizona
  • +46 more
Aug 30, 2012

Alzheimer, Parkinson Disease, Multiple Sclerosis Trial in New Haven ([18F]-FEPPA)

Completed
  • Alzheimer Disease
  • +2 more
  • New Haven, Connecticut
    Instiute for Neurodegenerative Disorders
Feb 7, 2012

Alzheimer Trial in New Haven ([18F] MNI-558)

Completed
  • Alzheimer Disease
  • [18F] MNI-558
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Jul 22, 2011

Alzheimer Trial in New Haven (MNI-513-01)

Terminated
  • Alzheimer Disease
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Oct 5, 2010

Alzheimer Trial in New Haven ([123I]AV94)

Terminated
  • Alzheimer Disease
  • New Haven, Connecticut
  • +1 more
Oct 5, 2010

Alzheimer Trial in New Haven (SPECT scan)

Terminated
  • Alzheimer Disease
  • SPECT scan
  • New Haven, Connecticut
  • +1 more
Oct 5, 2010

Alzheimer Trial in United States (Rofecoxib, Naproxen)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +39 more
Dec 10, 2009

Alzheimer Trial in United States (Investigational drug)

Terminated
  • Alzheimer Disease
  • Investigational drug
  • Peoria, Arizona
  • +33 more
Dec 10, 2009

Alzheimer Trial in New Haven ([123I] MNI-308)

Terminated
  • Alzheimer Disease
  • [123I] MNI-308
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Aug 20, 2009

Alzheimer Trial in United States (Simvastatin)

Completed
  • Alzheimer Disease
  • Birmingham, Alabama
  • +43 more
Jul 24, 2009

Alzheimer, Huntington Disease Trial in New Haven (digoxin, dimebon)

Completed
  • Alzheimer Disease
  • Huntington Disease
  • New Haven, Connecticut
    Pfizer Investigational Site
Jun 9, 2009

Alzheimer, Dementia Trial in United States (MPC-7869)

Completed
  • Alzheimer Disease
  • Dementia
  • Alabaster, Alabama
  • +132 more
May 3, 2009

Huntington Disease, Alzheimer Trial in New Haven (Dextromethorphan, Dimebon + Dextromethorphan)

Completed
  • Huntington Disease
  • Alzheimer Disease
  • New Haven, Connecticut
    Pfizer Investigational Site
Mar 5, 2009